Literature DB >> 2802112

IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa.

E Jarolim1, H Rumpold, A T Endler, H Ebner, M Breitenbach, O Scheiner, D Kraft.   

Abstract

IgE and IgG antibody response to birch pollen antigens were studied by means of immunoblotting experiments testing 58 sera from patients with Type I allergy to birch pollen. 56/58 patients showed IgE antibodies reactive with Bet v I, a 17 kilodalton (kD) pollen protein. 2D-electrophoresis/immunoblot revealed a heterogeneity of that protein. Ten spots (pH 4.9-5.9) could be detected, presumably representing differentially glycosylated isoallergens. In 33/58 patients, there was no evidence of IgE antibodies directed against allergens other than Bet v I. However, in 25/58 of patients' sera, 11 minor allergens (13, 15, 18, 27, 29, 32, 39, 44, 57, and 68 kD) with individual incidences from 1.7% to 17.2% were identified. All proteins were also recognized by the patients' IgG antibodies: in the case of Bet v I recognition was weak, whereas the IgG response to the minor allergens was pronounced. Sera from healthy individuals showed similar IgG antibody responses, but no IgG to the 15, 27, and 29 kD proteins. Our results suggest that IgG directed against minor allergens may function as trapping antibodies in healthy individuals. Too low or lacking amounts of anti-Bet v I IgG may facilitate an allergic reaction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802112     DOI: 10.1111/j.1398-9995.1989.tb04169.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  26 in total

Review 1.  Structural biology of allergens.

Authors:  Wayne R Thomas; Belinda J Hales; Wendy-Anne Smith
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.806

2.  Molecular characterization of a cytokinin-inducible periwinkle protein showing sequence homology with pathogenesis-related proteins and the Bet v 1 allergen family.

Authors:  S Carpin; S Laffer; F Schoentgen; R Valenta; J C Chénieux; M Rideau; S Hamdi
Journal:  Plant Mol Biol       Date:  1998-03       Impact factor: 4.076

Review 3.  Allergenic crossreactivities. Pollens and vegetable foods.

Authors:  R Fritsch; C Ebner; D Kraft
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.

Authors:  S Vrtala; K Hirtenlehner; L Vangelista; A Pastore; H G Eichler; W R Sperr; P Valent; C Ebner; D Kraft; R Valenta
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

Review 5.  T-cell epitopes of food allergens.

Authors:  Barbara Bohle
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

6.  Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen.

Authors:  U Wiedermann; B Jahn-Schmid; R Fritsch; L Bauer; H Renz; D Kraft; C Ebner
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  IgE binding to a new cross-reactive structure: a 35 kDa protein in birch pollen, exotic fruit and other plant foods.

Authors:  A Wellhausen; B Schöning; A Petersen; S Vieths
Journal:  Z Ernahrungswiss       Date:  1996-12

8.  [From the allergen-recognition by antibodies to new therapeutic concepts].

Authors:  Brigitte Hantusch; Erika Jensen-Jarolim
Journal:  Wien Med Wochenschr       Date:  2008

Review 9.  Mimotope vaccination--from allergy to cancer.

Authors:  Regina Knittelfelder; Angelika B Riemer; Erika Jensen-Jarolim
Journal:  Expert Opin Biol Ther       Date:  2009-04       Impact factor: 4.388

10.  Hydrocortisone enhances total IgE levels--but not the synthesis of allergen-specific IgE--in a monocyte-dependent manner.

Authors:  B Bohle; M Willheim; K Baier; B Stadler; S Spitzauer; O Scheiner; D Kraft; C Ebner
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.